Status:
COMPLETED
Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMO
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborating Sponsors:
Memorial Hermann Hospital
Conditions:
Persistent Fetal Circulation Syndrome
Diaphragmatic Hernia
Eligibility:
All Genders
1-30 years
Brief Summary
Infants are placed on ECMO for correction of reversible respiratory failure. Often, because a few of the reasons for respiratory failure show us similar things in the baby, it is difficult to determin...
Detailed Description
Specific Aims Primary Objective 1\. Determine the rise, peak, and fall of immunoglobulin isotype-specific ASC's, and immunoactive proteins (cytokines and chemokines) from sequential samples of periph...
Eligibility Criteria
Inclusion
- 1\) term newborn infants \>24 hours and ≤ 30 days old 2) Placed on ECMO in the NICU at MHCH 3) Parental consent obtained within 48 hours of being placed on ECMO
Exclusion
- 1\) Infant \> 30 days old 2) Infant NOT on ECMO 3) Withdrawal of parental consent
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00371241
Start Date
September 1 2006
End Date
November 1 2007
Last Update
November 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Hermann Hospital
Houston, Texas, United States, 77030